Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996

Journal of Chemotherapy

Volumn 11, Issue SUPPL. 1, 1999, Pages 5-21

  Felmingham, D ^a   Washington, J ^b  

^a GR Micro Ltd   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Alexander Project; Antimicrobial resistance; Respiratory tract infection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN;

ANTIBIOTIC RESISTANCE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONFERENCE PAPER; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PENICILLIN RESISTANCE; PREVALENCE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032925326     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.supplement-2.5     Document Type: Conference Paper

References (16)

1. Mandell LA. Community-acquired pneumonia: Etiology, epidemiology and treatment. Chest 1995; 108: 355-425.
2. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108: 435-452S.
3. Goldstein F, Bryskier A, Appelbaum PC, Bauernfeind A, Schito GC, Wise R. The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral bacterial agents against respiratory pathogens. Clin Microbiol Infect 1998; 4 (suppl 2): 2S8-2S18.
4. Felmingham D. Antibiotic resistance: Do we need new therapeutic approaches? Chest 1995; 108: 70S-78S.
5. Felmingham D, Grüneberg RN and the Alexander Project Group. A multicentre, collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 1996; 38 (suppl A): 11-57.
6. Grüneberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: a continuing, multicentre study of the antimicrobial susceptibility of community-acquired, lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169-181.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: seventh informational supplement. NCCLS document M100-S7 (ISBN 1-56238-309-4). Wayne, PA: NCCLS, 1997.
8. Doern GV, Brueggemann A, Holley Jr HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from out-patients in the United States during the winter months of 1994 to 1995: results of a 30-centre national surveillance study. Antimicrob Agents Chemother 1996; 40: 1208-1213.
9. Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on the collaborative surveillance study. J Antimicrob Chemother 1996; 38 (suppl A): 117-132.
10. Vogel F. A guide to the treatment of lower respiratory tract infections. Drugs 1995; 50: 62-72.
11. Woodnutt G, Berry V. The use of pharmacodynamic models to assess the efficacy of amoxicillin/clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Antimicrob Agents Chemother, in press.
12. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1-12.
13. Doern GV, Bruegemann AB, Pierce G, Holley Jr HP, Rauch M. Antibiotic resistance among clinical isolates of Haemophilus influenzas in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxycillin-clavulanate. Results of a national multicentre surveillance study. Antimicrob Agents Chemother 1977; 41: 292-297.
14. Clairoux N, Picard M, Brochu A et al. Molecular basis of the non-β-lactamase-mediated resistance of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother 1992; 36: 1504-1513.
15. Doern GV and The Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae - results of a 1992-1993 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996; 38 (suppl A): 59-69.
16. Berk SL, Kalbfleisch JH and The Alexander Project Collaborative Group. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. J Antimicrob Chemother 1996; 38 (suppl A): 85-96.